Abstract | BACKGROUND: METHODS: A randomized, crossover study was conducted in 10 chronic hemodialysis patients who were prone to hyperkalemia. Administration of 10 units of insulin with 100 ml of 50% glucose (50 g) was compared with the administration of 100 ml of 50% glucose only. Serum [K(+)] was measured up to 60 min. Patients were monitored for hypoglycemia and EKG changes. RESULTS: Baseline serum [K(+)] was 6.01 ± 0.87 and 6.23 ± 1.20 mmol/l in the insulin and glucose-only groups, respectively (p = 0.45). At 60 min, the glucose-only group had a fall in [K(+)] of 0.50 ± 0.31 mmol/l (p < 0.001). In the insulin group, there was a fall of 0.83 ± 0.53 mmol/l at 60 min (p < 0.001) and a lower serum [K(+)] at that time compared to the glucose-only group (5.18 ± 0.76 vs. 5.73 ± 1.12 mmol/l, respectively; p = 0.01). In the glucose-only group, the glucose area under the curve (AUC) was greater and the insulin AUC was smaller. Two patients in the insulin group developed hypoglycemia. CONCLUSION: Infusion of a glucose-only bolus caused a clinically significant decrease in serum [K(+)] without any episodes of hypoglycemia.
|
Authors | Mogamat-Yazied Chothia, Mitchell L Halperin, Megan A Rensburg, Mogamat Shafick Hassan, Mogamat Razeen Davids |
Journal | Nephron. Physiology
(Nephron Physiol)
Vol. 126
Issue 1
Pg. 1-8
( 2014)
ISSN: 1660-2137 [Electronic] Switzerland |
PMID | 24576893
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | 2014 S. Karger AG, Basel. |
Chemical References |
- Insulin
- Glucose
- Potassium
|
Topics |
- Administration, Intravenous
- Adult
- Cross-Over Studies
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Glucose
(administration & dosage, therapeutic use)
- Humans
- Hyperkalemia
(complications, drug therapy)
- Insulin
(administration & dosage, therapeutic use)
- Kidney Failure, Chronic
(complications, therapy)
- Male
- Potassium
(blood)
- Renal Dialysis
(methods)
- Treatment Outcome
|